Chimera Research Group – Mission Statement

Our Mission is to give each subscriber, retail or institutional, the most valuable insights and strategies in the biopharmaceutical sector. We strive to provide our subscribers with actionable market intelligence by leveraging the experience, accomplishments and intellectual horsepower of our founding members.

Are You Ready To Join?

   Join   

1

Proprietary Database

Access to our Proprietary Database which includes hundreds of companies with upcoming clinical catalysts that are searchable by sector, product, company, outlook and more. A tool to help find companies with upcoming clinical or regulatory opportunities.

2

Proprietary Calendar

Proprietary Calendar includes detailed clinical catalyst descriptions and contextual commentary to provide investors with relevant, searchable and insightful trade ideas. Our calendar also includes relevant corporate events and medical conference to provide you with a single source for upcoming events.

3

Research Reports

Access to our Research Reports, peer-reviewed by our team of exemplary analysts. Our research reports analyze clinical trials, pipelines, competitive landscapes, and more.

4

Trade Reports

Access to our Trade Reports which hinges on our in-depth anaylsis to provide the most favorable risk-reward profile. Our Trade Reports will seek to maximize profits or protect from losses through unparalleled statistical, scientific, fundamental and technical analysis.

5

Daily Update

Access to our daily update. Our analysts put together a daily update covering the major news in the biotech and pharmaceutical sectors.

6

Technical Analysis

Access to our Charts and Technical Analysis. Our analysts take you step-by-step through each chart, marking the technical entry and exit points, marking key support lines.

7

Forum

Our Forum is a unique place. It is a unified location where all of our subscribers interact with the Chimera Research Group founders and analysts, but also with each other. Our forums include contributions from hedge fund managers from some of the largest biotech hedge funds, as well as seasoned investors, pharmaceutical executives and more.

8

Proprietary News Feed

Access to our real-time aggregated News Feed that scours the web’s best content producers for medicine, pharmaceuticals, biotech, FDA approvals and more.

9

Real-Time Updates

Our service will get our cutting-edge information to our subscribers within seconds. Our Real-Time email alerts will arrive in your inbox in seconds. We also provide Real-Time Twitter & SMS updates as well as a Direct Email portal for instant communication.